Nuclear Medicine & Radio Pharmaceuticals Market Report

Europe Nuclear Medicine & Radio Pharmaceuticals Market Size, Status and Forecast 2014-2026

  • POSTDATE：Jun 08, 2020
  • PAGES：159
  • REPORT CODE：GMM539312
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The Nuclear Medicine & Radio Pharmaceuticals market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 4.5% during the forecast period. Focusing on the Europe market, this report analyzes the specific consumption structure, such as types and end users. In order to present the status of the circulation of this product in different Europe countries, this report covers top export and import countries to confirm the potential markets. Leading countries such as Germany, UK, France, Italy, Spain, Poland, Russia, Switzerland, Turkey, Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden), Benelux (Belgium, Netherlands, and Luxembourg), Baltic States (Estonia, Latvia, and Lithuania) and other countries, the market status and consumption potential of these countries are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Europe Nuclear Medicine & Radio Pharmaceuticals Market Segmentations:

    By Player:

    • Carestream

    • Biosensors International Group, Ltd

    • GE Healthcare

    • Shimadzu

    • Philips Healthcare

    • Toshiba

    • Hitachi

    • Siemens Healthcare

    • TriFoil Imaging

    • Esaote

    By Type:

    • Diagnostic Medicine: SPECT Radiopharmaceuticals, PET Radiopharmaceuticals

    • Therapeutic Medicine: Beta Emitters, Alpha Emitters, Brachytherapy Isotopes

    By End-User:

    • Application 1

    • Application 2

    • Application 3

    By Region:

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Poland

    • Russia

    • Switzerland

    • Turkey

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

      • Denmark

      • Finland

      • Norway

      • Sweden

      • Iceland

    • Benelux (Belgium, Netherlands, and Luxembourg)

      • Belgium

      • Netherlands

      • Luxembourg

    • Baltic States (Estonia, Latvia, and Lithuania)

      • Estonia

      • Latvia

      • Lithuania

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Nuclear Medicine & Radio Pharmaceuticals Market

    • 1.3 Market Segment by Type

    • 1.3.1 Europe Nuclear Medicine & Radio Pharmaceuticals Market Size and Growth Rate of Diagnostic Medicine: SPECT Radiopharmaceuticals, PET Radiopharmaceuticals from 2014 to 2026

    • 1.3.2 Europe Nuclear Medicine & Radio Pharmaceuticals Market Size and Growth Rate of Therapeutic Medicine: Beta Emitters, Alpha Emitters, Brachytherapy Isotopes from 2014 to 2026

    • 1.4 Market Segment by Application

    • 1.4.1 Europe Nuclear Medicine & Radio Pharmaceuticals Market Size and Growth Rate of Application 1 from 2014 to 2026

    • 1.4.2 Europe Nuclear Medicine & Radio Pharmaceuticals Market Size and Growth Rate of Application 2 from 2014 to 2026

    • 1.4.3 Europe Nuclear Medicine & Radio Pharmaceuticals Market Size and Growth Rate of Application 3 from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Germany Nuclear Medicine & Radio Pharmaceuticals Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 UK Nuclear Medicine & Radio Pharmaceuticals Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 France Nuclear Medicine & Radio Pharmaceuticals Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Italy Nuclear Medicine & Radio Pharmaceuticals Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Spain Nuclear Medicine & Radio Pharmaceuticals Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Poland Nuclear Medicine & Radio Pharmaceuticals Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Russia Nuclear Medicine & Radio Pharmaceuticals Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Switzerland Nuclear Medicine & Radio Pharmaceuticals Market Size and Growth Rate from 2014 to 2026

      • 1.5.9 Turkey Nuclear Medicine & Radio Pharmaceuticals Market Size and Growth Rate from 2014 to 2026

      • 1.5.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Nuclear Medicine & Radio Pharmaceuticals Market Size and Growth Rate from 2014 to 2026

      • 1.5.11 Benelux (Belgium, Netherlands, and Luxembourg) Nuclear Medicine & Radio Pharmaceuticals Market Size and Growth Rate from 2014 to 2026

      • 1.5.12 Baltic States (Estonia, Latvia, and Lithuania) Nuclear Medicine & Radio Pharmaceuticals Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Nuclear Medicine & Radio Pharmaceuticals Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Venders

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Nuclear Medicine & Radio Pharmaceuticals by Major Types

      • 3.4.1 Market Size and Growth Rate of Diagnostic Medicine: SPECT Radiopharmaceuticals, PET Radiopharmaceuticals

      • 3.4.2 Market Size and Growth Rate of Therapeutic Medicine: Beta Emitters, Alpha Emitters, Brachytherapy Isotopes

    4 Segmentation of Nuclear Medicine & Radio Pharmaceuticals Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Nuclear Medicine & Radio Pharmaceuticals by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Application 1 for Construction

      • 4.4.2 Market Size and Growth Rate of Application 2 for Construction

      • 4.4.3 Market Size and Growth Rate of Application 3 for Construction

    5 Market Analysis by Major Regions

    • 5.1 Europe Nuclear Medicine & Radio Pharmaceuticals Production Analysis by Top Regions

    • 5.2 Europe Nuclear Medicine & Radio Pharmaceuticals Consumption Analysis by Top Regions

    • 5.3 Europe Nuclear Medicine & Radio Pharmaceuticals Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 Germany Nuclear Medicine & Radio Pharmaceuticals Production, Import, Consumption and Export Analysis

      • 5.3.2 UK Nuclear Medicine & Radio Pharmaceuticals Production, Import, Consumption and Export Analysis

      • 5.3.3 France Nuclear Medicine & Radio Pharmaceuticals Production, Import, Consumption and Export Analysis

      • 5.3.4 Italy Nuclear Medicine & Radio Pharmaceuticals Production, Import, Consumption and Export Analysis

      • 5.3.5 Spain Nuclear Medicine & Radio Pharmaceuticals Production, Import, Consumption and Export Analysis

      • 5.3.6 Poland Nuclear Medicine & Radio Pharmaceuticals Production, Import, Consumption and Export Analysis

      • 5.3.7 Russia Nuclear Medicine & Radio Pharmaceuticals Production, Import, Consumption and Export Analysis

      • 5.3.8 Switzerland Nuclear Medicine & Radio Pharmaceuticals Production, Import, Consumption and Export Analysis

      • 5.3.9 Turkey Nuclear Medicine & Radio Pharmaceuticals Production, Import, Consumption and Export Analysis

      • 5.3.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Nuclear Medicine & Radio Pharmaceuticals Production, Import, Consumption and Export Analysis

      • 5.3.11 Benelux (Belgium, Netherlands, and Luxembourg) Nuclear Medicine & Radio Pharmaceuticals Production, Import, Consumption and Export Analysis

      • 5.3.12 Baltic States (Estonia, Latvia, and Lithuania) Nuclear Medicine & Radio Pharmaceuticals Production, Import, Consumption and Export Analysis

    6 Product Circulation of Nuclear Medicine & Radio Pharmaceuticals Market among Top Countries

    • 6.1 Top 5 Export Countries in Nuclear Medicine & Radio Pharmaceuticals Market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries’ Export Value Analysis in Nuclear Medicine & Radio Pharmaceuticals Market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries’ Export Volume Analysis in Nuclear Medicine & Radio Pharmaceuticals Market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Nuclear Medicine & Radio Pharmaceuticals Market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries’ Import Value Analysis in Nuclear Medicine & Radio Pharmaceuticals Market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries’ Import Volume Analysis in Nuclear Medicine & Radio Pharmaceuticals Market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7. Germany Nuclear Medicine & Radio Pharmaceuticals Landscape Analysis

    • 7.1 Germany Nuclear Medicine & Radio Pharmaceuticals Landscape Analysis by Major Types

    • 7.2 Germany Nuclear Medicine & Radio Pharmaceuticals Landscape Analysis by Major End-Users

    8. UK Nuclear Medicine & Radio Pharmaceuticals Landscape Analysis

    • 8.1 UK Nuclear Medicine & Radio Pharmaceuticals Landscape Analysis by Major Types

    • 8.2 UK Nuclear Medicine & Radio Pharmaceuticals Landscape Analysis by Major End-Users

    9. France Nuclear Medicine & Radio Pharmaceuticals Landscape Analysis

    • 9.1 France Nuclear Medicine & Radio Pharmaceuticals Landscape Analysis by Major Types

    • 9.2 France Nuclear Medicine & Radio Pharmaceuticals Landscape Analysis by Major End-Users

    10. Italy Nuclear Medicine & Radio Pharmaceuticals Landscape Analysis

    • 10.1 Italy Nuclear Medicine & Radio Pharmaceuticals Landscape Analysis by Major Types

    • 10.2 Italy Nuclear Medicine & Radio Pharmaceuticals Landscape Analysis by Major End-Users

    11. Spain Nuclear Medicine & Radio Pharmaceuticals Landscape Analysis

    • 11.1 Spain Nuclear Medicine & Radio Pharmaceuticals Landscape Analysis by Major Types

    • 11.2 Spain Nuclear Medicine & Radio Pharmaceuticals Landscape Analysis by Major End-Users

    12. Poland Nuclear Medicine & Radio Pharmaceuticals Landscape Analysis

    • 12.1 Poland Nuclear Medicine & Radio Pharmaceuticals Landscape Analysis by Major Types

    • 12.2 Poland Nuclear Medicine & Radio Pharmaceuticals Landscape Analysis by Major End-Users

    13. Russia Nuclear Medicine & Radio Pharmaceuticals Landscape Analysis

    • 13.1 Russia Nuclear Medicine & Radio Pharmaceuticals Landscape Analysis by Major Types

    • 13.2 Russia Nuclear Medicine & Radio Pharmaceuticals Landscape Analysis by Major End-Users

    14. Switzerland Nuclear Medicine & Radio Pharmaceuticals Landscape Analysis

    • 14.1 Switzerland Nuclear Medicine & Radio Pharmaceuticals Landscape Analysis by Major Types

    • 14.2 Switzerland Nuclear Medicine & Radio Pharmaceuticals Landscape Analysis by Major End-Users

    15. Turkey Nuclear Medicine & Radio Pharmaceuticals Landscape Analysis

    • 15.1 Turkey Nuclear Medicine & Radio Pharmaceuticals Landscape Analysis by Major Types

    • 15.2 Turkey Nuclear Medicine & Radio Pharmaceuticals Landscape Analysis by Major End-Users

    16. Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Nuclear Medicine & Radio Pharmaceuticals Landscape Analysis

    • 16.1 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Nuclear Medicine & Radio Pharmaceuticals Landscape Analysis by Major Types

    • 16.2 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Nuclear Medicine & Radio Pharmaceuticals Landscape Analysis by Major End-Users

    • 16.3 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Nuclear Medicine & Radio Pharmaceuticals Landscape Analysis by Top Countries

      • 16.3.1 Denmark Nuclear Medicine & Radio Pharmaceuticals Market Volume and Growth Rate

      • 16.3.2 Finland Nuclear Medicine & Radio Pharmaceuticals Market Volume and Growth Rate

      • 16.3.3 Norway Nuclear Medicine & Radio Pharmaceuticals Market Volume and Growth Rate

      • 16.3.4 Sweden Nuclear Medicine & Radio Pharmaceuticals Market Volume and Growth Rate

      • 16.3.6 Iceland Nuclear Medicine & Radio Pharmaceuticals Market Volume and Growth Rate

    17 Benelux (Belgium, Netherlands, and Luxembourg) Nuclear Medicine & Radio Pharmaceuticals Landscape Analysis

    • 17.1 Benelux (Belgium, Netherlands, and Luxembourg) Nuclear Medicine & Radio Pharmaceuticals Landscape Analysis by Major Types

    • 17.2 Benelux (Belgium, Netherlands, and Luxembourg) Nuclear Medicine & Radio Pharmaceuticals Landscape Analysis by Major End-Users

    • 17.3 Benelux (Belgium, Netherlands, and Luxembourg) Nuclear Medicine & Radio Pharmaceuticals Landscape Analysis by Top Countries

      • 17.3.1 Belgium Nuclear Medicine & Radio Pharmaceuticals Market Volume and Growth Rate

      • 17.3.2 Netherlands Nuclear Medicine & Radio Pharmaceuticals Market Volume and Growth Rate

      • 17.3.3 Luxembourg Nuclear Medicine & Radio Pharmaceuticals Market Volume and Growth Rate

    18 Baltic States (Estonia, Latvia, and Lithuania) Nuclear Medicine & Radio Pharmaceuticals Landscape Analysis

    • 18.1 Baltic States (Estonia, Latvia, and Lithuania) Nuclear Medicine & Radio Pharmaceuticals Landscape Analysis by Major Types

    • 18.2 Baltic States (Estonia, Latvia, and Lithuania) Nuclear Medicine & Radio Pharmaceuticals Landscape Analysis by Major End-Users

    • 18.3 Baltic States (Estonia, Latvia, and Lithuania) Nuclear Medicine & Radio Pharmaceuticals Landscape Analysis by Top Countries

      • 18.3.1 Estonia Nuclear Medicine & Radio Pharmaceuticals Market Volume and Growth Rate

      • 18.3.2 Latvia Nuclear Medicine & Radio Pharmaceuticals Market Volume and Growth Rate

      • 18.3.3 Lithuania Nuclear Medicine & Radio Pharmaceuticals Market Volume and Growth Rate

    19 Major Players Profiles

    • 19.1 Carestream

      • 19.1.1 Carestream Company Profile and Development Status

      • 19.1.2 Market Performance

      • 19.1.3 Product and Service Introduction

    • 19.2 Biosensors International Group, Ltd

      • 19.2.1 Biosensors International Group, Ltd Company Profile and Development Status

      • 19.2.2 Market Performance

      • 19.2.3 Product and Service Introduction

    • 19.3 GE Healthcare

      • 19.3.1 GE Healthcare Company Profile and Development Status

      • 19.3.2 Market Performance

      • 19.3.3 Product and Service Introduction

    • 19.4 Shimadzu

      • 19.4.1 Shimadzu Company Profile and Development Status

      • 19.4.2 Market Performance

      • 19.4.3 Product and Service Introduction

    • 19.5 Philips Healthcare

      • 19.5.1 Philips Healthcare Company Profile and Development Status

      • 19.5.2 Market Performance

      • 19.5.3 Product and Service Introduction

    • 19.6 Toshiba

      • 19.6.1 Toshiba Company Profile and Development Status

      • 19.6.2 Market Performance

      • 19.6.3 Product and Service Introduction

    • 19.7 Hitachi

      • 19.7.1 Hitachi Company Profile and Development Status

      • 19.7.2 Market Performance

      • 19.7.3 Product and Service Introduction

    • 19.8 Siemens Healthcare

      • 19.8.1 Siemens Healthcare Company Profile and Development Status

      • 19.8.2 Market Performance

      • 19.8.3 Product and Service Introduction

    • 19.9 TriFoil Imaging

      • 19.9.1 TriFoil Imaging Company Profile and Development Status

      • 19.9.2 Market Performance

      • 19.9.3 Product and Service Introduction

    • 19.10 Esaote

      • 19.10.1 Esaote Company Profile and Development Status

      • 19.10.2 Market Performance

      • 19.10.3 Product and Service Introduction

    The List of Tables and Figures (Totals 83 Figures and 159 Tables)

    • Figure Product Picture

    • Figure Nuclear Medicine & Radio Pharmaceuticals Market Size and Growth Rate of Diagnostic Medicine: SPECT Radiopharmaceuticals, PET Radiopharmaceuticals Market, 2015 - 2026 (USD Million)

    • Figure Nuclear Medicine & Radio Pharmaceuticals Market Size and Growth Rate of Therapeutic Medicine: Beta Emitters, Alpha Emitters, Brachytherapy Isotopes Market, 2015 - 2026 (USD Million)

    • Figure Nuclear Medicine & Radio Pharmaceuticals Market Size and Growth Rate of Application 1 from 2014 to 2026

    • Figure Nuclear Medicine & Radio Pharmaceuticals Market Size and Growth Rate of Application 2 from 2014 to 2026

    • Figure Nuclear Medicine & Radio Pharmaceuticals Market Size and Growth Rate of Application 3 from 2014 to 2026

    • Figure Germany Nuclear Medicine & Radio Pharmaceuticals Market Size and Growth Rate from 2014 to 2026

    • Figure UK Nuclear Medicine & Radio Pharmaceuticals Market Size and Growth Rate from 2014 to 2026

    • Figure France Nuclear Medicine & Radio Pharmaceuticals Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Nuclear Medicine & Radio Pharmaceuticals Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Nuclear Medicine & Radio Pharmaceuticals Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Nuclear Medicine & Radio Pharmaceuticals Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Nuclear Medicine & Radio Pharmaceuticals Market Size and Growth Rate from 2014 to 2026

    • Figure Switzerland Nuclear Medicine & Radio Pharmaceuticals Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Nuclear Medicine & Radio Pharmaceuticals Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Nuclear Medicine & Radio Pharmaceuticals Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Nuclear Medicine & Radio Pharmaceuticals Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Nuclear Medicine & Radio Pharmaceuticals Market Size and Growth Rate from 2014 to 2026

    • Figure Denmark Nuclear Medicine & Radio Pharmaceuticals Market Size and Growth Rate from 2014 to 2026

    • Figure Finland Nuclear Medicine & Radio Pharmaceuticals Market Size and Growth Rate from 2014 to 2026

    • Figure Norway Nuclear Medicine & Radio Pharmaceuticals Market Size and Growth Rate from 2014 to 2026

    • Figure Sweden Nuclear Medicine & Radio Pharmaceuticals Market Size and Growth Rate from 2014 to 2026

    • Figure Iceland Nuclear Medicine & Radio Pharmaceuticals Market Size and Growth Rate from 2014 to 2026

    • Figure Benelux (Belgium, Netherlands, and Luxembourg) Nuclear Medicine & Radio Pharmaceuticals Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Nuclear Medicine & Radio Pharmaceuticals Market Size and Growth Rate from 2014 to 2026

    • Figure Netherlands Nuclear Medicine & Radio Pharmaceuticals Market Size and Growth Rate from 2014 to 2026

    • Figure Luxembourg Nuclear Medicine & Radio Pharmaceuticals Market Size and Growth Rate from 2014 to 2026

    • Figure Baltic States (Estonia, Latvia, and Lithuania) Nuclear Medicine & Radio Pharmaceuticals Market Size and Growth Rate from 2014 to 2026

    • Figure Estonia Nuclear Medicine & Radio Pharmaceuticals Market Size and Growth Rate from 2014 to 2026

    • Figure Latvia Nuclear Medicine & Radio Pharmaceuticals Market Size and Growth Rate from 2014 to 2026

    • Figure Lithuania Nuclear Medicine & Radio Pharmaceuticals Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Nuclear Medicine & Radio Pharmaceuticals Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Nuclear Medicine & Radio Pharmaceuticals

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Nuclear Medicine & Radio Pharmaceuticals by Different Types from 2014 to 2026

    • Table Consumption Share of Nuclear Medicine & Radio Pharmaceuticals by Different Types from 2014 to 2026

    • Figure Nuclear Medicine & Radio Pharmaceuticals Market Size and Growth Rate of Diagnostic Medicine: SPECT Radiopharmaceuticals, PET Radiopharmaceuticals Market, 2015 - 2026 (USD Million)

    • Figure Nuclear Medicine & Radio Pharmaceuticals Market Size and Growth Rate of Therapeutic Medicine: Beta Emitters, Alpha Emitters, Brachytherapy Isotopes Market, 2015 - 2026 (USD Million)

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Nuclear Medicine & Radio Pharmaceuticals by Different End-Users from 2014 to 2026

    • Table Consumption Share of Nuclear Medicine & Radio Pharmaceuticals by Different End-Users from 2014 to 2026

    • Figure Nuclear Medicine & Radio Pharmaceuticals Market Size and Growth Rate of Application 1 from 2014 to 2026

    • Figure Nuclear Medicine & Radio Pharmaceuticals Market Size and Growth Rate of Application 2 from 2014 to 2026

    • Figure Nuclear Medicine & Radio Pharmaceuticals Market Size and Growth Rate of Application 3 from 2014 to 2026

    • Table Europe Nuclear Medicine & Radio Pharmaceuticals Production by Major Regions

    • Table Europe Nuclear Medicine & Radio Pharmaceuticals Production Share by Major Regions

    • Figure Europe Nuclear Medicine & Radio Pharmaceuticals Production Share by Major Countries and Regions in 2014

    • Table Europe Nuclear Medicine & Radio Pharmaceuticals Consumption by Major Regions

    • Table Europe Nuclear Medicine & Radio Pharmaceuticals Consumption Share by Major Regions

    • Table Germany Nuclear Medicine & Radio Pharmaceuticals Production, Import, Consumption and Export Analysis

    • Table UK Nuclear Medicine & Radio Pharmaceuticals Production, Import, Consumption and Export Analysis

    • Table France Nuclear Medicine & Radio Pharmaceuticals Production, Import, Consumption and Export Analysis

    • Table Italy Nuclear Medicine & Radio Pharmaceuticals Production, Import, Consumption and Export Analysis

    • Table Spain Nuclear Medicine & Radio Pharmaceuticals Production, Import, Consumption and Export Analysis

    • Table Poland Nuclear Medicine & Radio Pharmaceuticals Production, Import, Consumption and Export Analysis

    • Table Russia Nuclear Medicine & Radio Pharmaceuticals Production, Import, Consumption and Export Analysis

    • Table Switzerland Nuclear Medicine & Radio Pharmaceuticals Production, Import, Consumption and Export Analysis

    • Table Turkey Nuclear Medicine & Radio Pharmaceuticals Production, Import, Consumption and Export Analysis

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Nuclear Medicine & Radio Pharmaceuticals Production, Import, Consumption and Export Analysis

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Nuclear Medicine & Radio Pharmaceuticals Production, Import, Consumption and Export Analysis

    • Table Baltic States (Estonia, Latvia, and Lithuania) Nuclear Medicine & Radio Pharmaceuticals Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Nuclear Medicine & Radio Pharmaceuticals Market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Nuclear Medicine & Radio Pharmaceuticals Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Nuclear Medicine & Radio Pharmaceuticals Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Nuclear Medicine & Radio Pharmaceuticals Market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table Germany Nuclear Medicine & Radio Pharmaceuticals Consumption by Types from 2014 to 2026

    • Table Germany Nuclear Medicine & Radio Pharmaceuticals Consumption Share by Types from 2014 to 2026

    • Table Germany Nuclear Medicine & Radio Pharmaceuticals Consumption by End-Users from 2014 to 2026

    • Table Germany Nuclear Medicine & Radio Pharmaceuticals Consumption Share by End-Users from 2014 to 2026

    • Table UK Nuclear Medicine & Radio Pharmaceuticals Consumption by Types from 2014 to 2026

    • Table UK Nuclear Medicine & Radio Pharmaceuticals Consumption Share by Types from 2014 to 2026

    • Table UK Nuclear Medicine & Radio Pharmaceuticals Consumption by End-Users from 2014 to 2026

    • Table UK Nuclear Medicine & Radio Pharmaceuticals Consumption Share by End-Users from 2014 to 2026

    • Table France Nuclear Medicine & Radio Pharmaceuticals Consumption by Types from 2014 to 2026

    • Table France Nuclear Medicine & Radio Pharmaceuticals Consumption Share by Types from 2014 to 2026

    • Table France Nuclear Medicine & Radio Pharmaceuticals Consumption by End-Users from 2014 to 2026

    • Table France Nuclear Medicine & Radio Pharmaceuticals Consumption Share by End-Users from 2014 to 2026

    • Table Italy Nuclear Medicine & Radio Pharmaceuticals Consumption by Types from 2014 to 2026

    • Table Italy Nuclear Medicine & Radio Pharmaceuticals Consumption Share by Types from 2014 to 2026

    • Table Italy Nuclear Medicine & Radio Pharmaceuticals Consumption by End-Users from 2014 to 2026

    • Table Italy Nuclear Medicine & Radio Pharmaceuticals Consumption Share by End-Users from 2014 to 2026

    • Table Spain Nuclear Medicine & Radio Pharmaceuticals Consumption by Types from 2014 to 2026

    • Table Spain Nuclear Medicine & Radio Pharmaceuticals Consumption Share by Types from 2014 to 2026

    • Table Spain Nuclear Medicine & Radio Pharmaceuticals Consumption by End-Users from 2014 to 2026

    • Table Spain Nuclear Medicine & Radio Pharmaceuticals Consumption Share by End-Users from 2014 to 2026

    • Table Poland Nuclear Medicine & Radio Pharmaceuticals Consumption by Types from 2014 to 2026

    • Table Poland Nuclear Medicine & Radio Pharmaceuticals Consumption Share by Types from 2014 to 2026

    • Table Poland Nuclear Medicine & Radio Pharmaceuticals Consumption by End-Users from 2014 to 2026

    • Table Poland Nuclear Medicine & Radio Pharmaceuticals Consumption Share by End-Users from 2014 to 2026

    • Table Russia Nuclear Medicine & Radio Pharmaceuticals Consumption by Types from 2014 to 2026

    • Table Russia Nuclear Medicine & Radio Pharmaceuticals Consumption Share by Types from 2014 to 2026

    • Table Russia Nuclear Medicine & Radio Pharmaceuticals Consumption by End-Users from 2014 to 2026

    • Table Russia Nuclear Medicine & Radio Pharmaceuticals Consumption Share by End-Users from 2014 to 2026

    • Table Switzerland Nuclear Medicine & Radio Pharmaceuticals Consumption by Types from 2014 to 2026

    • Table Switzerland Nuclear Medicine & Radio Pharmaceuticals Consumption Share by Types from 2014 to 2026

    • Table Switzerland Nuclear Medicine & Radio Pharmaceuticals Consumption by End-Users from 2014 to 2026

    • Table Switzerland Nuclear Medicine & Radio Pharmaceuticals Consumption Share by End-Users from 2014 to 2026

    • Table Turkey Nuclear Medicine & Radio Pharmaceuticals Consumption by Types from 2014 to 2026

    • Table Turkey Nuclear Medicine & Radio Pharmaceuticals Consumption Share by Types from 2014 to 2026

    • Table Turkey Nuclear Medicine & Radio Pharmaceuticals Consumption by End-Users from 2014 to 2026

    • Table Turkey Nuclear Medicine & Radio Pharmaceuticals Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Nuclear Medicine & Radio Pharmaceuticals Consumption by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Nuclear Medicine & Radio Pharmaceuticals Consumption Share by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Nuclear Medicine & Radio Pharmaceuticals Consumption by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Nuclear Medicine & Radio Pharmaceuticals Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Nuclear Medicine & Radio Pharmaceuticals Consumption by Major Countries from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Nuclear Medicine & Radio Pharmaceuticals Consumption Share by Major Countries from 2014 to 2026

    • Figure Denmark Nuclear Medicine & Radio Pharmaceuticals Market Volume and Growth Rate from 2014 to 2026

    • Figure Finland Nuclear Medicine & Radio Pharmaceuticals Market Volume and Growth Rate from 2014 to 2026

    • Figure Norway Nuclear Medicine & Radio Pharmaceuticals Market Volume and Growth Rate from 2014 to 2026

    • Figure Sweden Nuclear Medicine & Radio Pharmaceuticals Market Volume and Growth Rate from 2014 to 2026

    • Figure Iceland Nuclear Medicine & Radio Pharmaceuticals Market Volume and Growth Rate from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Nuclear Medicine & Radio Pharmaceuticals Consumption by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Nuclear Medicine & Radio Pharmaceuticals Consumption Share by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Nuclear Medicine & Radio Pharmaceuticals Consumption by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Nuclear Medicine & Radio Pharmaceuticals Consumption Share by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Nuclear Medicine & Radio Pharmaceuticals Consumption by Major Countries from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Nuclear Medicine & Radio Pharmaceuticals Consumption Share by Major Countries from 2014 to 2026

    • Figure Belgium Nuclear Medicine & Radio Pharmaceuticals Market Volume and Growth Rate from 2014 to 2026

    • Figure Netherlands Nuclear Medicine & Radio Pharmaceuticals Market Volume and Growth Rate from 2014 to 2026

    • Figure Luxembourg Nuclear Medicine & Radio Pharmaceuticals Market Volume and Growth Rate from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Nuclear Medicine & Radio Pharmaceuticals Consumption by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Nuclear Medicine & Radio Pharmaceuticals Consumption Share by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Nuclear Medicine & Radio Pharmaceuticals Consumption by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Nuclear Medicine & Radio Pharmaceuticals Consumption Share by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Nuclear Medicine & Radio Pharmaceuticals Consumption by Major Countries from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Nuclear Medicine & Radio Pharmaceuticals Consumption Share by Major Countries from 2014 to 2026

    • Figure Estonia Nuclear Medicine & Radio Pharmaceuticals Market Volume and Growth Rate from 2014 to 2026

    • Figure Latvia Nuclear Medicine & Radio Pharmaceuticals Market Volume and Growth Rate from 2014 to 2026

    • Figure Lithuania Countries Nuclear Medicine & Radio Pharmaceuticals Market Volume and Growth Rate from 2014 to 2026

    • Table Carestream Profiles

    • Table Carestream Production, Value, Price, Gross Margin 2014-2019

    • Table Carestream Product benchmarking

    • Table Carestream Strategic initiatives

    • Table Carestream SWOT analysis

    • Table Biosensors International Group, Ltd Profiles

    • Table Biosensors International Group, Ltd Production, Value, Price, Gross Margin 2014-2019

    • Table Biosensors International Group, Ltd Product benchmarking

    • Table Biosensors International Group, Ltd Strategic initiatives

    • Table Biosensors International Group, Ltd SWOT analysis

    • Table GE Healthcare Profiles

    • Table GE Healthcare Production, Value, Price, Gross Margin 2014-2019

    • Table GE Healthcare Product benchmarking

    • Table GE Healthcare Strategic initiatives

    • Table GE Healthcare SWOT analysis

    • Table Shimadzu Profiles

    • Table Shimadzu Production, Value, Price, Gross Margin 2014-2019

    • Table Shimadzu Product benchmarking

    • Table Shimadzu Strategic initiatives

    • Table Shimadzu SWOT analysis

    • Table Philips Healthcare Profiles

    • Table Philips Healthcare Production, Value, Price, Gross Margin 2014-2019

    • Table Philips Healthcare Product benchmarking

    • Table Philips Healthcare Strategic initiatives

    • Table Philips Healthcare SWOT analysis

    • Table Toshiba Profiles

    • Table Toshiba Production, Value, Price, Gross Margin 2014-2019

    • Table Toshiba Product benchmarking

    • Table Toshiba Strategic initiatives

    • Table Toshiba SWOT analysis

    • Table Hitachi Profiles

    • Table Hitachi Production, Value, Price, Gross Margin 2014-2019

    • Table Hitachi Product benchmarking

    • Table Hitachi Strategic initiatives

    • Table Hitachi SWOT analysis

    • Table Siemens Healthcare Profiles

    • Table Siemens Healthcare Production, Value, Price, Gross Margin 2014-2019

    • Table Siemens Healthcare Product benchmarking

    • Table Siemens Healthcare Strategic initiatives

    • Table Siemens Healthcare SWOT analysis

    • Table TriFoil Imaging Profiles

    • Table TriFoil Imaging Production, Value, Price, Gross Margin 2014-2019

    • Table TriFoil Imaging Product benchmarking

    • Table TriFoil Imaging Strategic initiatives

    • Table TriFoil Imaging SWOT analysis

    • Table Esaote Profiles

    • Table Esaote Production, Value, Price, Gross Margin 2014-2019

    • Table Esaote Product benchmarking

    • Table Esaote Strategic initiatives

    • Table Esaote SWOT analysis

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US